世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

Global Precision Medicine Market 2023-2027


Technavio Announces the Publication of its Research Report - Global Precision Medicine Market 2023-2027 Technavio recognizes the following companies as the key players in the global precision medi... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechNavio
テクナビオ
2023年5月4日 US$2,500
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
171 英語

 

Summary

Technavio Announces the Publication of its Research Report - Global Precision Medicine Market 2023-2027
Technavio recognizes the following companies as the key players in the global precision medicine market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Biocrates Life Sciences AG, Bristol Myers Squibb Co., Catalent Inc., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., IQVIA Holdings Inc., Johnson and Johnson Services Inc., Lonza Group Ltd., Merck and Co. Inc., Novartis AG, Parexel International Corp., Pfizer Inc., QIAGEN NV, Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Thermo Fisher Scientific Inc.
Commenting on the report, an analyst from Technavio said: "The latest trend gaining momentum in the market is growing use of artificial intelligence (AI) and machine learning (ML) in precision medicine."
According to the report, one of the major drivers for this market is the growing prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- https://www.technavio.com/report/precision-medicine-market-analysis
Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- https://www.technavio.com/industries/pharmaceuticals
Follow us on Twitter @Technavio

ページTOPに戻る


Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global precision medicine market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global precision medicine market 2017 - 2021 ($ billion)
o 4.2 Application Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
o 4.3 Technology Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Application
o 6.1 Market segments
o Exhibit 30: Chart on Application - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
o 6.2 Comparison by Application
o Exhibit 32: Chart on Comparison by Application
o Exhibit 33: Data Table on Comparison by Application
o 6.3 Oncology - Market size and forecast 2022-2027
o Exhibit 34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
o 6.4 CNS - Market size and forecast 2022-2027
o Exhibit 38: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on CNS - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
o 6.5 Respiratory - Market size and forecast 2022-2027
o Exhibit 42: Chart on Respiratory - Market size and forecast 2022-2027 ($ billion)
o Exhibit 43: Data Table on Respiratory - Market size and forecast 2022-2027 ($ billion)
o Exhibit 44: Chart on Respiratory - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Respiratory - Year-over-year growth 2022-2027 (%)
o 6.6 Immunology - Market size and forecast 2022-2027
o Exhibit 46: Chart on Immunology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 47: Data Table on Immunology - Market size and forecast 2022-2027 ($ billion)
o Exhibit 48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
o 6.7 Others - Market size and forecast 2022-2027
o Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
o Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.8 Market opportunity by Application
o Exhibit 54: Market opportunity by Application ($ billion)
o Exhibit 55: Data Table on Market opportunity by Application ($ billion)
• 7 Market Segmentation by Technology
o 7.1 Market segments
o Exhibit 56: Chart on Technology - Market share 2022-2027 (%)
o Exhibit 57: Data Table on Technology - Market share 2022-2027 (%)
o 7.2 Comparison by Technology
o Exhibit 58: Chart on Comparison by Technology
o Exhibit 59: Data Table on Comparison by Technology
o 7.3 Bioinformatics - Market size and forecast 2022-2027
o Exhibit 60: Chart on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Bioinformatics - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Bioinformatics - Year-over-year growth 2022-2027 (%)
o 7.4 Gene sequencing - Market size and forecast 2022-2027
o Exhibit 64: Chart on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
o Exhibit 65: Data Table on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
o Exhibit 66: Chart on Gene sequencing - Year-over-year growth 2022-2027 (%)
o Exhibit 67: Data Table on Gene sequencing - Year-over-year growth 2022-2027 (%)
o 7.5 Drug discovery - Market size and forecast 2022-2027
o Exhibit 68: Chart on Drug discovery - Market size and forecast 2022-2027 ($ billion)
o Exhibit 69: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ billion)
o Exhibit 70: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
o Exhibit 71: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
o 7.6 Precision molecular diagnostic - Market size and forecast 2022-2027
o Exhibit 72: Chart on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Data Table on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
o Exhibit 74: Chart on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
o Exhibit 75: Data Table on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
o 7.7 Big data analytics - Market size and forecast 2022-2027
o Exhibit 76: Chart on Big data analytics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Data Table on Big data analytics - Market size and forecast 2022-2027 ($ billion)
o Exhibit 78: Chart on Big data analytics - Year-over-year growth 2022-2027 (%)
o Exhibit 79: Data Table on Big data analytics - Year-over-year growth 2022-2027 (%)
o 7.8 Market opportunity by Technology
o Exhibit 80: Market opportunity by Technology ($ billion)
o Exhibit 81: Data Table on Market opportunity by Technology ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 83: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 85: Chart on Geographic comparison
o Exhibit 86: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 103: Chart on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
o Exhibit 109: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 China - Market size and forecast 2022-2027
o Exhibit 111: Chart on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
o Exhibit 113: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 114: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.10 UK - Market size and forecast 2022-2027
o Exhibit 115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
o Exhibit 117: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 118: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.11 Japan - Market size and forecast 2022-2027
o Exhibit 119: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 120: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
o Exhibit 121: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 122: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 123: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 125: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 126: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 127: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 128: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 129: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 130: Matrix on vendor position and classification
o 12.3 Amgen Inc.
o Exhibit 131: Amgen Inc. - Overview
o Exhibit 132: Amgen Inc. - Product / Service
o Exhibit 133: Amgen Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 134: AstraZeneca Plc - Overview
o Exhibit 135: AstraZeneca Plc - Product / Service
o Exhibit 136: AstraZeneca Plc - Key news
o Exhibit 137: AstraZeneca Plc - Key offerings
o 12.5 Bristol Myers Squibb Co.
o Exhibit 138: Bristol Myers Squibb Co. - Overview
o Exhibit 139: Bristol Myers Squibb Co. - Product / Service
o Exhibit 140: Bristol Myers Squibb Co. - Key news
o Exhibit 141: Bristol Myers Squibb Co. - Key offerings
o 12.6 Catalent Inc.
o Exhibit 142: Catalent Inc. - Overview
o Exhibit 143: Catalent Inc. - Business segments
o Exhibit 144: Catalent Inc. - Key news
o Exhibit 145: Catalent Inc. - Key offerings
o Exhibit 146: Catalent Inc. - Segment focus
o 12.7 Eli Lilly and Co.
o Exhibit 147: Eli Lilly and Co. - Overview
o Exhibit 148: Eli Lilly and Co. - Product / Service
o Exhibit 149: Eli Lilly and Co. - Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 150: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 151: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 152: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 153: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 154: F. Hoffmann La Roche Ltd. - Segment focus
o 12.9 Gilead Sciences Inc.
o Exhibit 155: Gilead Sciences Inc. - Overview
o Exhibit 156: Gilead Sciences Inc. - Product / Service
o Exhibit 157: Gilead Sciences Inc. - Key news
o Exhibit 158: Gilead Sciences Inc. - Key offerings
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 159: Johnson and Johnson Services Inc. - Overview
o Exhibit 160: Johnson and Johnson Services Inc. - Business segments
o Exhibit 161: Johnson and Johnson Services Inc. - Key news
o Exhibit 162: Johnson and Johnson Services Inc. - Key offerings
o Exhibit 163: Johnson and Johnson Services Inc. - Segment focus
o 12.11 Lonza Group Ltd.
o Exhibit 164: Lonza Group Ltd. - Overview
o Exhibit 165: Lonza Group Ltd. - Business segments
o Exhibit 166: Lonza Group Ltd. - Key news
o Exhibit 167: Lonza Group Ltd. - Key offerings
o Exhibit 168: Lonza Group Ltd. - Segment focus
o 12.12 Merck and Co. Inc.
o Exhibit 169: Merck and Co. Inc. - Overview
o Exhibit 170: Merck and Co. Inc. - Business segments
o Exhibit 171: Merck and Co. Inc. - Key news
o Exhibit 172: Merck and Co. Inc. - Key offerings
o Exhibit 173: Merck and Co. Inc. - Segment focus
o 12.13 Novartis AG
o Exhibit 174: Novartis AG - Overview
o Exhibit 175: Novartis AG - Business segments
o Exhibit 176: Novartis AG - Key offerings
o Exhibit 177: Novartis AG - Segment focus
o 12.14 Pfizer Inc.
o Exhibit 178: Pfizer Inc. - Overview
o Exhibit 179: Pfizer Inc. - Product / Service
o Exhibit 180: Pfizer Inc. - Key news
o Exhibit 181: Pfizer Inc. - Key offerings
o 12.15 Sanofi SA
o Exhibit 182: Sanofi SA - Overview
o Exhibit 183: Sanofi SA - Business segments
o Exhibit 184: Sanofi SA - Key news
o Exhibit 185: Sanofi SA - Key offerings
o Exhibit 186: Sanofi SA - Segment focus
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 187: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 188: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 189: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 190: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Thermo Fisher Scientific Inc.
o Exhibit 191: Thermo Fisher Scientific Inc. - Overview
o Exhibit 192: Thermo Fisher Scientific Inc. - Business segments
o Exhibit 193: Thermo Fisher Scientific Inc. - Key news
o Exhibit 194: Thermo Fisher Scientific Inc. - Key offerings
o Exhibit 195: Thermo Fisher Scientific Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 196: Inclusions checklist
o Exhibit 197: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 198: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 199: Research methodology
o Exhibit 200: Validation techniques employed for market sizing
o Exhibit 201: Information sources
o 13.5 List of abbreviations
o Exhibit 202: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global precision medicine market 2017 - 2021 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
Exhibits20: Historic Market Size - Technology Segment 2017 - 2021 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Oncology - Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oncology - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on CNS - Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on CNS - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on CNS - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Respiratory - Market size and forecast 2022-2027 ($ billion)
Exhibits43: Data Table on Respiratory - Market size and forecast 2022-2027 ($ billion)
Exhibits44: Chart on Respiratory - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Respiratory - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Immunology - Market size and forecast 2022-2027 ($ billion)
Exhibits47: Data Table on Immunology - Market size and forecast 2022-2027 ($ billion)
Exhibits48: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
Exhibits52: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits53: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits54: Market opportunity by Application ($ billion)
Exhibits55: Data Table on Market opportunity by Application ($ billion)
Exhibits56: Chart on Technology - Market share 2022-2027 (%)
Exhibits57: Data Table on Technology - Market share 2022-2027 (%)
Exhibits58: Chart on Comparison by Technology
Exhibits59: Data Table on Comparison by Technology
Exhibits60: Chart on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Bioinformatics - Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Bioinformatics - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Bioinformatics - Year-over-year growth 2022-2027 (%)
Exhibits64: Chart on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
Exhibits65: Data Table on Gene sequencing - Market size and forecast 2022-2027 ($ billion)
Exhibits66: Chart on Gene sequencing - Year-over-year growth 2022-2027 (%)
Exhibits67: Data Table on Gene sequencing - Year-over-year growth 2022-2027 (%)
Exhibits68: Chart on Drug discovery - Market size and forecast 2022-2027 ($ billion)
Exhibits69: Data Table on Drug discovery - Market size and forecast 2022-2027 ($ billion)
Exhibits70: Chart on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits71: Data Table on Drug discovery - Year-over-year growth 2022-2027 (%)
Exhibits72: Chart on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
Exhibits73: Data Table on Precision molecular diagnostic - Market size and forecast 2022-2027 ($ billion)
Exhibits74: Chart on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits75: Data Table on Precision molecular diagnostic - Year-over-year growth 2022-2027 (%)
Exhibits76: Chart on Big data analytics - Market size and forecast 2022-2027 ($ billion)
Exhibits77: Data Table on Big data analytics - Market size and forecast 2022-2027 ($ billion)
Exhibits78: Chart on Big data analytics - Year-over-year growth 2022-2027 (%)
Exhibits79: Data Table on Big data analytics - Year-over-year growth 2022-2027 (%)
Exhibits80: Market opportunity by Technology ($ billion)
Exhibits81: Data Table on Market opportunity by Technology ($ billion)
Exhibits82: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits83: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits84: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits85: Chart on Geographic comparison
Exhibits86: Data Table on Geographic comparison
Exhibits87: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits107: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits108: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits109: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits110: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits111: Chart on China - Market size and forecast 2022-2027 ($ billion)
Exhibits112: Data Table on China - Market size and forecast 2022-2027 ($ billion)
Exhibits113: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits114: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits115: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits116: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits117: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits118: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits119: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits120: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits121: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits122: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits123: Market opportunity By Geographical Landscape ($ billion)
Exhibits124: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits125: Impact of drivers and challenges in 2022 and 2027
Exhibits126: Overview on Criticality of inputs and Factors of differentiation
Exhibits127: Overview on factors of disruption
Exhibits128: Impact of key risks on business
Exhibits129: Vendors covered
Exhibits130: Matrix on vendor position and classification
Exhibits131: Amgen Inc. - Overview
Exhibits132: Amgen Inc. - Product / Service
Exhibits133: Amgen Inc. - Key offerings
Exhibits134: AstraZeneca Plc - Overview
Exhibits135: AstraZeneca Plc - Product / Service
Exhibits136: AstraZeneca Plc - Key news
Exhibits137: AstraZeneca Plc - Key offerings
Exhibits138: Bristol Myers Squibb Co. - Overview
Exhibits139: Bristol Myers Squibb Co. - Product / Service
Exhibits140: Bristol Myers Squibb Co. - Key news
Exhibits141: Bristol Myers Squibb Co. - Key offerings
Exhibits142: Catalent Inc. - Overview
Exhibits143: Catalent Inc. - Business segments
Exhibits144: Catalent Inc. - Key news
Exhibits145: Catalent Inc. - Key offerings
Exhibits146: Catalent Inc. - Segment focus
Exhibits147: Eli Lilly and Co. - Overview
Exhibits148: Eli Lilly and Co. - Product / Service
Exhibits149: Eli Lilly and Co. - Key offerings
Exhibits150: F. Hoffmann La Roche Ltd. - Overview
Exhibits151: F. Hoffmann La Roche Ltd. - Business segments
Exhibits152: F. Hoffmann La Roche Ltd. - Key news
Exhibits153: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits154: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits155: Gilead Sciences Inc. - Overview
Exhibits156: Gilead Sciences Inc. - Product / Service
Exhibits157: Gilead Sciences Inc. - Key news
Exhibits158: Gilead Sciences Inc. - Key offerings
Exhibits159: Johnson and Johnson Services Inc. - Overview
Exhibits160: Johnson and Johnson Services Inc. - Business segments
Exhibits161: Johnson and Johnson Services Inc. - Key news
Exhibits162: Johnson and Johnson Services Inc. - Key offerings
Exhibits163: Johnson and Johnson Services Inc. - Segment focus
Exhibits164: Lonza Group Ltd. - Overview
Exhibits165: Lonza Group Ltd. - Business segments
Exhibits166: Lonza Group Ltd. - Key news
Exhibits167: Lonza Group Ltd. - Key offerings
Exhibits168: Lonza Group Ltd. - Segment focus
Exhibits169: Merck and Co. Inc. - Overview
Exhibits170: Merck and Co. Inc. - Business segments
Exhibits171: Merck and Co. Inc. - Key news
Exhibits172: Merck and Co. Inc. - Key offerings
Exhibits173: Merck and Co. Inc. - Segment focus
Exhibits174: Novartis AG - Overview
Exhibits175: Novartis AG - Business segments
Exhibits176: Novartis AG - Key offerings
Exhibits177: Novartis AG - Segment focus
Exhibits178: Pfizer Inc. - Overview
Exhibits179: Pfizer Inc. - Product / Service
Exhibits180: Pfizer Inc. - Key news
Exhibits181: Pfizer Inc. - Key offerings
Exhibits182: Sanofi SA - Overview
Exhibits183: Sanofi SA - Business segments
Exhibits184: Sanofi SA - Key news
Exhibits185: Sanofi SA - Key offerings
Exhibits186: Sanofi SA - Segment focus
Exhibits187: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits188: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits189: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits190: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits191: Thermo Fisher Scientific Inc. - Overview
Exhibits192: Thermo Fisher Scientific Inc. - Business segments
Exhibits193: Thermo Fisher Scientific Inc. - Key news
Exhibits194: Thermo Fisher Scientific Inc. - Key offerings
Exhibits195: Thermo Fisher Scientific Inc. - Segment focus
Exhibits196: Inclusions checklist
Exhibits197: Exclusions checklist
Exhibits198: Currency conversion rates for US$
Exhibits199: Research methodology
Exhibits200: Validation techniques employed for market sizing
Exhibits201: Information sources
Exhibits202: List of abbreviations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


TechNavio社はどのような調査会社ですか?


テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15 10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る